NEW YORK, NY. March 6. Depleting the number of harmful B cells with a novel immunotherapy that employs modified T cells may offer an effective strategy to treat lupus, according to a new study funded ...

Vision – To be the world's leading and most trusted provider of information and services that will make a real difference in clinical practice and improve outcomes for patients. Mission – To lead the ...

For permission requests, please contact NEJM Reprints at [email protected] Select the format you want to export the citation of this publication.

Lupus, or systemic lupus erythematosus (SLE), is a chronic, multisystem, autoimmune disorder with a heterogeneity of presentation so remarkable that is has also been termed “the disease with a ...

For permission requests, please contact NEJM Reprints at [email protected] ...